During the last three years of this grant we discovered that the inotropic action of Beta-adrenergic agonists consists of separate and dissociable functional alterations of sarcolemmal calcium flux and sarcoplasmic reticulum calcium sequestration. Zero sodium solutions eliminate the positive inotropic action of isoproterenol, the stimulation of the slow inward calcium current and markedly reduce the rise in intracellular cyclic AMP without altering the relaxant effect of isoproterenol which decreases the time for peak tension development. Our recent success in the development of low background, high affinity reversible and irreversible probes for the Beta-adrenergic receptor and projected additional high molecular weight, electron dense and fluorescent probes should facilitate the functional and anatomical localization of Beta-adrenergic receptors and sites of cyclic AMP generation in the myocardium. The original observation by this laboratory that RNA and protein synthesis inhibitors prevent catecholamine refractoriness will be a focus for studies of the mechanism of catecholamine refractoriness. There is widespread confirmation that RNA and protein synthesis are involved in refractoriness in a wide variety of cell types and hormones. While cyclase can be isolated which shows some refractoriness, the quantitative aspects reflect only a fraction of the dramatic rise in isoproterenol stimulated cyclic AMP accumulation and subsequent refractoriness observed in whole cells. Because of this, acute cell fusion experiments have been initiated and have already demonstrated the ability to acutely transfer altered responsiveness from one cell to the next. This technique will be used to identify and isolate the factor(s) which impart refractoriness. Additional experiments are proposed in this supplemental application to further evaluate our recent finding that long term treatment of cultured cells with isoproterenol or cholera toxin results in a cyclic AMP mediated loss of Beta-adrenergic receptor binding sites. The mechanism of cyclic AMP mediated receptor loss will be investigated to determine if cyclic AMP reduces receptor synthesis or modifies receptor binding by some covalent modification of the receptor.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL028940-05
Application #
3340147
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1981-09-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1987-06-30
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
School of Medicine & Dentistry
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
DeBernardi, Maria A; Brooker, Gary (2006) High-content kinetic calcium imaging in drug-sensitive and drug-resistant human breast cancer cells. Methods Enzymol 414:317-35
Bachis, A; Colangelo, A M; Vicini, S et al. (2001) Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21:3104-12
DeBernardi, M A; Brooker, G (1998) Simultaneous fluorescence ratio imaging of cyclic AMP and calcium kinetics in single living cells. Adv Second Messenger Phosphoprotein Res 32:195-213
O'Reilly, J P; Jiang, C; Haddad, G G (1995) Major differences in response to graded hypoxia between hypoglossal and neocortical neurons. Brain Res 683:179-86
Krishnan, S N; Haddad, G G (1995) Cloning of glucose transporter-3 (GLUT3) cDNA from rat brain. Life Sci 56:1193-7
de Erausquin, G; Brooker, G; Costa, E et al. (1994) Persistent AMPA receptor stimulation alters [Ca2+]i homeostasis in cultures of embryonic dopaminergic neurons. Brain Res Mol Brain Res 21:303-11
Mattie, M; Brooker, G; Spiegel, S (1994) Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem 269:3181-8
Debernardi, M A; Munshi, R; Yoshimura, M et al. (1993) Predominant expression of type-VI adenylate cyclase in C6-2B rat glioma cells may account for inhibition of cyclic AMP accumulation by calcium. Biochem J 293 ( Pt 2):325-8
Debernardi, M A; Munshi, R; Brooker, G (1993) Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C. Mol Pharmacol 43:451-8
Munshi, R; DeBernardi, M A; Brooker, G (1993) P2U-purinergic receptors on C6-2B rat glioma cells: modulation of cytosolic Ca2+ and cAMP levels by protein kinase C. Mol Pharmacol 44:1185-91

Showing the most recent 10 out of 24 publications